Jeriza Rusit

541 total citations
8 papers, 442 citations indexed

About

Jeriza Rusit is a scholar working on Molecular Biology, Ophthalmology and Rheumatology. According to data from OpenAlex, Jeriza Rusit has authored 8 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Ophthalmology and 3 papers in Rheumatology. Recurrent topics in Jeriza Rusit's work include Systemic Lupus Erythematosus Research (3 papers), Complement system in diseases (2 papers) and Retinal Diseases and Treatments (2 papers). Jeriza Rusit is often cited by papers focused on Systemic Lupus Erythematosus Research (3 papers), Complement system in diseases (2 papers) and Retinal Diseases and Treatments (2 papers). Jeriza Rusit collaborates with scholars based in New Zealand, France and United States. Jeriza Rusit's co-authors include Jacques Gaudreault, David Fei, John R. Lowe, Maurício Maia, Eric Wakshull, Anan Chuntharapai, Lin Xu, Patrick Liu, Valerie Quarmby and Sunil R. Lakhani and has published in prestigious journals such as Investigative Ophthalmology & Visual Science, Journal of Immunological Methods and Journal of Pharmaceutical and Biomedical Analysis.

In The Last Decade

Jeriza Rusit

7 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeriza Rusit New Zealand 4 375 275 158 35 14 8 442
Mark Chittum United States 8 450 1.2× 239 0.9× 108 0.7× 23 0.7× 9 0.6× 8 496
Liran Tiosano Israel 14 491 1.3× 312 1.1× 126 0.8× 28 0.8× 18 1.3× 36 568
Carl J. Danzig United States 11 349 0.9× 193 0.7× 142 0.9× 16 0.5× 15 1.1× 20 425
Kourous A. Rezaei United States 7 338 0.9× 220 0.8× 140 0.9× 55 1.6× 16 1.1× 22 429
Hansjuergen Agostini Germany 12 385 1.0× 267 1.0× 68 0.4× 14 0.4× 6 0.4× 31 465
Robert B. Garoon United States 8 245 0.7× 131 0.5× 84 0.5× 14 0.4× 9 0.6× 15 302
Roman Dunavoelgyi Austria 13 432 1.2× 245 0.9× 66 0.4× 10 0.3× 26 1.9× 27 464
Bjorn Bakker Netherlands 12 385 1.0× 226 0.8× 128 0.8× 131 3.7× 35 2.5× 19 488
Athanasios I. Kotsolis United States 10 543 1.4× 319 1.2× 78 0.5× 5 0.1× 23 1.6× 24 595
Óscar Ruiz‐Moreno Spain 10 267 0.7× 152 0.6× 69 0.4× 4 0.1× 32 2.3× 34 314

Countries citing papers authored by Jeriza Rusit

Since Specialization
Citations

This map shows the geographic impact of Jeriza Rusit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeriza Rusit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeriza Rusit more than expected).

Fields of papers citing papers by Jeriza Rusit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeriza Rusit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeriza Rusit. The network helps show where Jeriza Rusit may publish in the future.

Co-authorship network of co-authors of Jeriza Rusit

This figure shows the co-authorship network connecting the top 25 collaborators of Jeriza Rusit. A scholar is included among the top collaborators of Jeriza Rusit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeriza Rusit. Jeriza Rusit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Lowe, John R., et al.. (2018). Development and validation of a novel semi-homogenous clinical assay for quantitation of Ranibizumab in human serum. Journal of Immunological Methods. 461. 44–52. 11 indexed citations
2.
Le, Kha, et al.. (2013). Analysis of 24 month data from the HARBOR study indicates that anti-therapeutic antibodies status had no significant impact on the treatment response to ranibizumab. Investigative Ophthalmology & Visual Science. 54(15). 3793–3793. 2 indexed citations
3.
Lowe, John R., Maurício Maia, Eric Wakshull, et al.. (2010). Development of a novel homogenous electrochemiluminescence assay for quantitation of ranibizumab in human serum. Journal of Pharmaceutical and Biomedical Analysis. 52(5). 680–686. 10 indexed citations
4.
Haughney, Peter C., John R. Lowe, Jeriza Rusit, et al.. (2005). Clinical Pharmacokinetics of Ranibizumab (LucentisTM) in Subjects With AMD. Investigative Ophthalmology & Visual Science. 46(13). 1383–1383. 7 indexed citations
5.
Gaudreault, Jacques, et al.. (2005). Preclinical Pharmacokinetics of Ranibizumab (rhuFabV2) after a Single Intravitreal Administration. Investigative Ophthalmology & Visual Science. 46(2). 726–726. 408 indexed citations
6.
Gaudreault, Jacques, et al.. (2004). A Pharmacokinetic Model Describing Ocular And Systemic Disposition Of Ranibizumab In Rabbits. Investigative Ophthalmology & Visual Science. 45(13). 1854–1854. 2 indexed citations
7.
Damico, Lisa A., et al.. (2004). Pharmacokinetic study of ranibizumab (LucentisTM) following subconjunctival, intracameral and intravitreal administration in rabbits. Investigative Ophthalmology & Visual Science. 45(13). 3952–3952. 1 indexed citations
8.
Gaudreault, Jacques, et al.. (2003). Ocular Pharmacokinetics and Antipermeability Effect of rhuFab V2 in Animals. Investigative Ophthalmology & Visual Science. 44(13). 3942–3942. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark Chittum Breakdown of academic impact, for papers by Liran Tiosano Breakdown of academic impact, for papers by Carl J. Danzig Breakdown of academic impact, for papers by Kourous A. Rezaei Breakdown of academic impact, for papers by Hansjuergen Agostini Breakdown of academic impact, for papers by Robert B. Garoon Breakdown of academic impact, for papers by Roman Dunavoelgyi Breakdown of academic impact, for papers by Bjorn Bakker Breakdown of academic impact, for papers by Athanasios I. Kotsolis Breakdown of academic impact, for papers by Óscar Ruiz‐Moreno
Rankless by CCL
2026